Recent Conferences
November 24, 2008
Medicare Delivery System Reform
October 2, 2008
Specialty Pharmaceuticals: Policy Solutions for Encouraging Access and Affordability
July 16, 2008
Managing Specialty Pharmaceuticals
June 4, 2008
"Road Testing" Electronic Medical Records
April 30, 2008
Innovation Workgroup
April 10, 2008
Payment and Delivery System Reform
November 29, 2007
Comparative Effectiveness Congressional Briefing
November 27, 2007
Overview of Cost Management Strategies
October 24, 2007
Coverage With Evidence Development
October 2, 2007
Value-Based Payment for Medical Technologies
September 18, 2007
Personalized Medicine Conference
July 25, 2007
Comparative Effectiveness: Stakeholder Perspectives
April 11, 2007
Post Marketing Surveillance
November 30, 2006
Comparative Effectiveness Forum
October 12, 2006
Coverage Policy in an Era of Personalized Medicine
July 13, 2006
Pharmaceutical Benefit Management
May 1, 2006
Methodology Standards
April 4, 2006
Technology Assessment
October 3, 2005
Promoting Appropriate Utilization
April 1, 2005
Evidence-Based Health Care System
July 16, 2004
Correcting Underuse in Health Care
May 1, 2006
When Methodology Meets Policy: Methodology Standards to Support Improved Evidence for Decision Making
Health plans and purchasers increasingly demand evidence beyond what is necessary for FDA approval to justify reimbursement and coverage decisions. This meeting examined the strengths and limitations of different approaches to evaluating medical technologies and services including: observational studies, systematic review, and prospective comparative trials. Participants then debated which types of study methodologies were suitable for answering different types of questions. Participants also discussed what policymakers should know about different study methodologies in order to inform future funding of clinical and health services research.
Presentations:
Systemic Evidence Reviews: Improving Their Use for Policy Makers
David Atkins, M.D., MPH, Chief Medical Officer, Agency for Healthcare Research and Quality
The Need for Improvements in Methodology to Support Evidence Development
Marc L. Berger, M.D., Vice President, Outcomes Research & Management, Merck & Co., Inc.
Observational Studies to Provide Evidence for Decision Making
Nancy Dreyer, Chief of Scientific Affairs, Outcome, Inc.
Sean Tunis, M.D., MSc, Center for Health Technology Policy
